Malin’s investee company Poseida Therapeutics has filed for a potential IPO.

Life sciences investment company Malin said on Monday that its investee company Poseida Therapeutics has filed for a potential initial public offering(...)

Ian Curley and other executives are  due to present details of the group’s review at a capital markets day in London early next month

Dublin-listed life sciences investment firm Malin has announced the departure of chief executive Adrian Howd after just one year in the post. The tro(...)

Kelly Martin, former chief executive of Elan and co-founder of Malin. He left Malin in October last year, receiving a €3.2m exit settlement, compared to the €6.5m to which he was entitled.

Shareholders in Malin Corporation, the Dublin-based life sciences investment firm that’s reviewing its strategy in the wake of a share price slump and(...)